ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 71 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,280 | -61.4% | 31,525 | -47.1% | 0.00% | -100.0% |
| Q2 2023 | $213,368 | -80.7% | 59,600 | -88.2% | 0.00% | -66.7% |
| Q1 2023 | $1,103,636 | +4.5% | 506,255 | +210.6% | 0.00% | -25.0% |
| Q3 2022 | $1,056,000 | -63.9% | 163,015 | -74.5% | 0.00% | -60.0% |
| Q2 2022 | $2,929,000 | -38.5% | 639,557 | +16.1% | 0.01% | -28.6% |
| Q1 2022 | $4,766,000 | -17.0% | 550,956 | +37.0% | 0.01% | +16.7% |
| Q4 2021 | $5,742,000 | – | 402,097 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |